Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology

scientific article

Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2012PLoSO...732419P
P356DOI10.1371/JOURNAL.PONE.0032419
P932PMC publication ID3293807
P698PubMed publication ID22403656
P5875ResearchGate publication ID221689535

P2093author name stringJohn H Wolfe
Ramona Rozen
Michael K Parente
Cassia N Cearley
P2860cites workAnalysis of gene regulatory networks in the mammalian circadian rhythmQ21563498
Gene ontology: tool for the unification of biologyQ23781406
Expression cloning of a functional glycoprotein ligand for P-selectinQ24304912
Olfactory marker protein (OMP) gene deletion causes altered physiological activity of olfactory sensory neuronsQ24320122
A gene network regulating lysosomal biogenesis and functionQ24339409
Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiencyQ24626591
Expression of the homeobox genes OTX2 and OTX1 in the early developing human brainQ24631258
KEGG for representation and analysis of molecular networks involving diseases and drugsQ24644514
Molecular dissection of reactive astrogliosis and glial scar formationQ24646628
Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotectionQ24650675
Genome-wide atlas of gene expression in the adult mouse brainQ26253934
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesQ27860739
The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responsesQ28114771
Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transferQ28115950
A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesionsQ28204617
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways.Q51547401
Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease.Q51899182
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).Q51899563
From wild wolf to domestic dog: gene expression changes in the brain.Q54710402
Olfactory marker protein modulates primary olfactory axon overshooting in the olfactory bulbQ57641854
Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cellsQ84126765
The impact of the extracellular matrix on inflammationQ28294058
Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB miceQ28472880
Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblastsQ28573446
Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neuronsQ28584202
Lgi4 promotes the proliferation and differentiation of glial lineage cells throughout the developing peripheral nervous systemQ28588175
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and functionQ29547320
Mechanisms underlying inflammation in neurodegenerationQ29617977
TM4 microarray software suiteQ29618829
Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune responseQ30495848
Dissection of hippocampal dentate gyrus from adult mouse.Q30890249
Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathyQ33439351
Common and uncommon pathogenic cascades in lysosomal storage diseasesQ33966917
Patterning the cranial neural crest: hindbrain segmentation and Hox gene plasticityQ34185517
Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosisQ34205101
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIBQ34762478
Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnucleiQ35871922
GeneTrail--advanced gene set enrichment analysisQ35914072
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammationQ36361058
Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factorsQ36713851
The role of astrocytes and complement system in neural plasticity.Q36902271
Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approachesQ36902298
Role of OPG/RANKL/RANK axis on the vasculatureQ37070441
Neuropeptide interactions and REM sleep: a role for Urotensin II?Q37135968
Proteomics of the lysosomeQ37196950
Regional and strain-specific gene expression mapping in the adult mouse brainQ37271547
Immunomodulatory and anti-inflammatory effects of chondroitin sulphateQ37310621
Lysosomal disorders: from storage to cellular damageQ37359176
Pathogenic cascades in lysosomal disease-Why so complex?Q37364596
Hox genes and segmentation of the hindbrain and axial skeletonQ37540204
Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration.Q37702453
Olfactory system: functional organization and involvement in neurodegenerative diseaseQ37790556
The role of otx2 in adult mesencephalic-diencephalic dopaminergic neuronsQ37810501
Functions of Chondroitin Sulfate and Heparan Sulfate in the Developing BrainQ37812566
Signaling pathways in reactive astrocytes, a genetic perspectiveQ37828480
The stem cell potential of glia: lessons from reactive gliosisQ37830315
Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vectorQ39611260
Urotensin II evokes neurotransmitter release from rat cerebrocortical slicesQ39969296
Innate and adaptive immune activation in the brain of MPS IIIB mouse model.Q40033388
Somatic gene therapy for a neurodegenerative disease using microencapsulated recombinant cellsQ40841413
Cellular pathology of lysosomal storage disorders.Q40870656
Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brainQ41358776
Relationship between olfactory function and olfactory neuronal population in C57BL6 mice injected intraperitoneally with 3‐methylindoleQ42792030
l-arginine:glycine amidinotransferase (AGAT) deficiency: clinical presentation and response to treatment in two patients with a novel mutationQ42947826
Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.Q43003656
Beta-glucuronidase mediated pathway essential for retinal pigment epithelial degradation of glycosaminoglycans. Disease expression and in vitro disease correction using retroviral mediated cDNA transferQ43822158
OMP gene deletion results in an alteration in odorant-induced mucosal activity patternsQ44548805
Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronidesQ44710659
Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype.Q45864337
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2.Q46003783
Induction of early growth response-1 mediates microglia activation in vitro but is dispensable in vivo.Q46051764
A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegenerationQ46882495
Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.Q48136972
Differential gene expression of aldolase C (ALDOC) and hypoxic adaptation in chickensQ48150863
Variant clinical course of mucopolysaccharidosis type VII in two groups of mice carrying the same mutation.Q48309593
Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversibleQ48439549
Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation.Q48515364
Immune system-related CD9 is expressed in mouse central nervous system myelin at a very late stage of myelinationQ48539694
Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation.Q48612902
Neuropathology of murine mucopolysaccharidosis type VII.Q48852047
Identification of new markers for neurodegeneration process in the mouse model of Sly disease as revealed by expression profiling of selected genesQ49051031
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectlysosomal storage diseaseQ675010
P304page(s)e32419
P577publication date2012-03-05
P1433published inPLOS OneQ564954
P1476titleDysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology
P478volume7

Reverse relations

cites work (P2860)
Q26853349Animal models for lysosomal storage disorders
Q43671074Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?
Q35664978Bilateral single-site intracerebral injection of a nonpathogenic herpes simplex virus-1 vector decreases anxiogenic behavior in MPS VII mice
Q33755372Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model
Q41838423Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease
Q37705073Clinical neurogenetics: neuropathic lysosomal storage disorders
Q36278875Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.
Q27318087Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
Q35623843Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model
Q89682420Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies
Q42100984High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model.
Q35180647Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease
Q27318642Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I
Q40217404Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus
Q58571217Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons
Q91591025Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease
Q26753109Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis
Q59340084New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
Q33980271Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis
Q37238697Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
Q51758684The Aging of Iron Man.
Q89697806Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies
Q53540627Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease.
Q91185200Variation among intact tissue samples reveals the core transcriptional features of human CNS cell classes
Q37076523β-glucuronidase mRNA levels are correlated with gait and working memory in premutation females: understanding the role of FMR1 premutation alleles

Search more.